Paper39089
Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
Gruetter CA and 5 others. J Cyclic Nucleotide Res, 1979. Cited by 549 papers, by iCite.
Cite this record
ConductScience Library. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. Papers, record 39089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39089
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferricyanides | Major topic |
| Guanylate Cyclase | Major topic |
| Methylnitronitrosoguanidine | Major topic |
| Muscle, Smooth, Vascular | Major topic |
| Nitric Oxide | Major topic |
| Nitroprusside | Major topic |
| Animals | |
| Arteries | |
| Cattle | |
| Coronary Vessels | |
| Enzyme Activation | |
| Hemeproteins | |
| Muscle Relaxation |
Source PubMed
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 549 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41188152 | Gasotransmitter signaling in the brain: New frontiers for therapeutics. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/41188152 | PubMed |
| 40769850 | Hydrogen sulfide/polysulfides signaling and neuronal diseases. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/40769850 | PubMed |
| 40760267 | Efficacy of Treating Nifedipine-Induced Shock with Hydroxocobalamin in a Swine Model. | J Med Toxicol | 2025 | https://conductscience.org/library/papers/40760267 | PubMed |
| 40560510 | Evidence-Based Supplementation Strategies for Wrestlers: A Systematic Review. | Curr Nutr Rep | 2025 | https://conductscience.org/library/papers/40560510 | PubMed |
| 37189703 | Nitric Oxide in Cardiac Surgery: A Review Article. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189703 | PubMed |
| 36984866 | Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling. | Metabolites | 2023 | https://conductscience.org/library/papers/36984866 | PubMed |
| 36432022 | Biological Assessment of the NO-Dependent Endothelial Function. | Molecules | 2022 | https://conductscience.org/library/papers/36432022 | PubMed |
| 35754072 | Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases. | Intensive Care Med Exp | 2022 | https://conductscience.org/library/papers/35754072 | PubMed |
| 35745248 | An Exploration of How Solar Radiation Affects the Seasonal Variation of Human Mortality Rates and the Seasonal Variation in Some Other Common Disorders. | Nutrients | 2022 | https://conductscience.org/library/papers/35745248 | PubMed |
| 35616143 | Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review). | Mol Med Rep | 2022 | https://conductscience.org/library/papers/35616143 | PubMed |
| 35076566 | Nitric Oxide: The Missing Factor in COVID-19 Severity? | Med Sci (Basel) | 2021 | https://conductscience.org/library/papers/35076566 | PubMed |
| 34365128 | Gemfibrozil derivatives as activators of soluble guanylyl cyclase - A structure-activity study. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/34365128 | PubMed |
| 32370259 | Senescence and Cancer: Role of Nitric Oxide (NO) in SASP. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32370259 | PubMed |
| 31187898 | Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling. | Compr Physiol | 2019 | https://conductscience.org/library/papers/31187898 | PubMed |
| 30587924 | Cytoprotective effects of molsidomine against methotrexate-induced hepatotoxicity: an experimental rat study. | Drug Des Devel Ther | 2019 | https://conductscience.org/library/papers/30587924 | PubMed |
| 30556130 | Nitric oxide is not just blowing in the wind. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/30556130 | PubMed |
| 30308037 | Effects of the nitric oxide releasing biomimetic nanomatrix gel on pulp-dentin regeneration: Pilot study. | PLoS One | 2018 | https://conductscience.org/library/papers/30308037 | PubMed |
| 30063800 | Nitric oxide and its role as a non-adrenergic, non-cholinergic inhibitory neurotransmitter in the gastrointestinal tract. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/30063800 | PubMed |
| 29744429 | Nanomaterials for treating cardiovascular diseases: A review. | Bioact Mater | 2017 | https://conductscience.org/library/papers/29744429 | PubMed |
| 29552696 | Mechanism of vasorelaxation induced by 3'-hydroxy-5,6,7,4'-tetramethoxyflavone in the rats aortic ring assay. | Naunyn Schmiedebergs Arch Pharmacol | 2018 | https://conductscience.org/library/papers/29552696 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39089
GET https://conductscience.org/api/papers/v1/39089/cited_by?page=2